UnitedHealth Group Shares Surge 5% on Upgraded Price Targets
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 day ago
0mins
Source: stocktwits
- Analyst Target Upgrades: Morgan Stanley analyst Erin Wright raised UnitedHealth's price target from $395 to $453 while maintaining an ‘Overweight’ rating, indicating over 12% upside potential from current levels, reflecting increased market confidence in the healthcare giant.
- Improving Medical Cost Trends: BofA analyst Kevin Fischbeck upgraded UnitedHealth's rating from ‘Neutral’ to ‘Buy’ with a new price target of $450, noting that first-quarter medical cost trends exceeded consensus expectations, which is expected to drive favorable second-quarter performance.
- Shifting Market Sentiment: According to Stocktwits data, retail sentiment around UnitedHealth has shifted from ‘bearish’ to ‘neutral’, with message volumes increasing from ‘low’ to ‘normal’, indicating a recovery in investor confidence regarding the company's future prospects.
- Strong Earnings Report: UnitedHealth reported first-quarter revenue of $111.7 billion, surpassing analyst expectations, while adjusted earnings came in at $7.23 per share, significantly exceeding Wall Street's estimate of $6.61, showcasing the company's robust performance and profitability in the healthcare insurance market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UNH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UNH
Wall Street analysts forecast UNH stock price to rise
19 Analyst Rating
16 Buy
3 Hold
0 Sell
Strong Buy
Current: 396.470
Low
330.00
Averages
397.82
High
444.00
Current: 396.470
Low
330.00
Averages
397.82
High
444.00
About UNH
UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
UnitedHealth Group Shares Surge 5% on Upgraded Price Targets
- Analyst Target Upgrades: Morgan Stanley analyst Erin Wright raised UnitedHealth's price target from $395 to $453 while maintaining an ‘Overweight’ rating, indicating over 12% upside potential from current levels, reflecting increased market confidence in the healthcare giant.
- Improving Medical Cost Trends: BofA analyst Kevin Fischbeck upgraded UnitedHealth's rating from ‘Neutral’ to ‘Buy’ with a new price target of $450, noting that first-quarter medical cost trends exceeded consensus expectations, which is expected to drive favorable second-quarter performance.
- Shifting Market Sentiment: According to Stocktwits data, retail sentiment around UnitedHealth has shifted from ‘bearish’ to ‘neutral’, with message volumes increasing from ‘low’ to ‘normal’, indicating a recovery in investor confidence regarding the company's future prospects.
- Strong Earnings Report: UnitedHealth reported first-quarter revenue of $111.7 billion, surpassing analyst expectations, while adjusted earnings came in at $7.23 per share, significantly exceeding Wall Street's estimate of $6.61, showcasing the company's robust performance and profitability in the healthcare insurance market.
See More
Managed Care Stocks Surge Led by UnitedHealth
- Market Recovery: After a 35% decline last year, UnitedHealth (UNH) has surged approximately 21% year-to-date, indicating a strong rebound in the managed care sector, particularly led by the Medicare Advantage market.
- Payment Rate Increase: The Centers for Medicare & Medicaid Services finalized a 3% payment hike for Medicare Advantage players for next year, reflecting an improving backdrop of care utilization that further fuels optimism in the industry.
- Analyst Rating Upgrade: Following Bank of America's upgrade of UnitedHealth from Neutral to Buy, the stock rose about 5% on Thursday, with analyst Kevin Fischbeck projecting a broader managed care rally if utilization trends continue to improve.
- Attractive Valuations: Despite the positive outlook, UnitedHealth's EV/EBITDA valuation is roughly in line with its five-year average, while CVS Health shows only a ~7% premium, suggesting that the sector still has room for further upside given the favorable setup.
See More
Analysts Upgrade Nvidia and Microsoft on AI Leadership and Margin Resilience
- Nvidia Upgrade: Analyst Ritabrata Das upgraded Nvidia from Hold to Buy, citing its significant benefits from AI infrastructure development, particularly the Blackwell architecture and the high switching costs associated with the CUDA ecosystem, which provide a strong competitive moat.
- Microsoft Rating Reversal: Kevin George upgraded Microsoft from Sell to Buy, noting that AI-driven product launches and improved margin dynamics are offsetting the pressures from high capital expenditures, with net margins continuing to rise despite increased spending.
- UnitedHealth Downgrade: Envision Research downgraded UnitedHealth from Buy to Hold, warning that recent profit margins may be unsustainable due to looming regulatory risks and political pressures in the Medicare Advantage sector, highlighting the volatility in investor sentiment.
- Lululemon Downgrade: Analyst Gary Alexander downgraded Lululemon to Neutral following weak Q1 results and a cut to full-year guidance, expressing concerns over slowing comparable sales and competitive pressures, suggesting that the stock is unlikely to see an upward re-rating in the near term.
See More
Lowe's, Medtronic, and UnitedHealth Raise Dividends
- Lowe's Dividend Increase: Lowe's announced a 4% increase in its quarterly dividend to $1.25 per share, and despite a 14% decline in stock price this year, its 2.4% yield remains significantly above the S&P 500's 1% average.
- Medtronic's Revenue Growth: Medtronic reported an 8.4% annual revenue growth for fiscal 2026, reaching $36.4 billion, and raised its dividend to $0.72, marking the 49th consecutive year of increases, underscoring its appeal as a quality dividend stock.
- UnitedHealth's Dividend Boost: UnitedHealth increased its quarterly dividend by 5% to $2.32 per share, with a 60% rise over the past five years, averaging a compounded annual growth rate of about 10%, providing investors with a hedge against inflation.
- Healthcare Sector Outlook: While Medtronic and UnitedHealth's stock prices have fallen by 15% and risen by 20% respectively this year, their forward P/E ratios of 12 and 21 indicate strong appeal for dividend investors, particularly in the medical devices and health insurance sectors.
See More
Three High-Yield Stocks Increase Dividends
- Lowe's Dividend Increase: Lowe's announced a 4% increase in its quarterly dividend to $1.25 per share, yielding 2.4%, which is significantly higher than the S&P 500's 1%, despite a 14% drop in stock price this year; this move underscores the company's long-standing commitment to dividend payments, as home repairs remain essential for homeowners in the long run.
- Medtronic Annual Performance: Medtronic reported a record revenue of $36.4 billion for fiscal 2026, an 8.4% increase year-over-year, and raised its dividend to $0.72 per share, marking the 49th consecutive year of increases; while the increment is modest, its 3.5% yield continues to attract investors, reflecting its solid position in the medical device sector.
- UnitedHealth Dividend Boost: UnitedHealth increased its quarterly dividend by 5% to $2.32 per share, with a remarkable 60% rise over the past five years, averaging a 10% compound annual growth rate, which not only offsets inflation but also boosts investor confidence in its future performance, as the stock has risen 20% this year while remaining reasonably priced.
- Market Outlook Analysis: All three companies demonstrate strong performance in their respective sectors, and despite market fluctuations, Lowe's and Medtronic's low P/E ratios of 16 and 12 make them attractive options for investors, while UnitedHealth's improved control over medical expenses provides confidence for future growth.
See More
Surge in Options Trading for Healthcare Stocks
- Healthcare Stocks Surge: On Thursday, healthcare stocks outperformed as the broader market rose, with insurers Humana and Centene hitting new highs and UnitedHealth Group nearing its one-year peak, indicating a strong recovery in the sector and increased investor confidence.
- Active Options Trading: The State Street Health Care Select Sector SPDR ETF (XLV) saw 5,300 call options traded on Thursday, significantly outpacing just over 1,000 puts, reflecting bullish sentiment and expectations for future growth in the healthcare industry.
- Eli Lilly Leads Gains: Eli Lilly's stock rose over 4% towards all-time highs, with call options outnumbering puts more than two-to-one, showcasing strong demand for its weight loss drugs and confidence in future profitability.
- Comparative Financial Sector Performance: In contrast to the robust performance of healthcare stocks, options trading in the financial sector appeared muted, with nearly 380,000 options traded in the State Street Financial Select Sector ETF (XLF), indicating a more cautious market outlook for financials.
See More
UnitedHealth Group Shares Surge 5% on Upgraded Price Targets
- Analyst Target Upgrades: Morgan Stanley analyst Erin Wright raised UnitedHealth's price target from $395 to $453 while maintaining an ‘Overweight’ rating, indicating over 12% upside potential from current levels, reflecting increased market confidence in the healthcare giant.
- Improving Medical Cost Trends: BofA analyst Kevin Fischbeck upgraded UnitedHealth's rating from ‘Neutral’ to ‘Buy’ with a new price target of $450, noting that first-quarter medical cost trends exceeded consensus expectations, which is expected to drive favorable second-quarter performance.
- Shifting Market Sentiment: According to Stocktwits data, retail sentiment around UnitedHealth has shifted from ‘bearish’ to ‘neutral’, with message volumes increasing from ‘low’ to ‘normal’, indicating a recovery in investor confidence regarding the company's future prospects.
- Strong Earnings Report: UnitedHealth reported first-quarter revenue of $111.7 billion, surpassing analyst expectations, while adjusted earnings came in at $7.23 per share, significantly exceeding Wall Street's estimate of $6.61, showcasing the company's robust performance and profitability in the healthcare insurance market.
See More
Managed Care Stocks Surge Led by UnitedHealth
- Market Recovery: After a 35% decline last year, UnitedHealth (UNH) has surged approximately 21% year-to-date, indicating a strong rebound in the managed care sector, particularly led by the Medicare Advantage market.
- Payment Rate Increase: The Centers for Medicare & Medicaid Services finalized a 3% payment hike for Medicare Advantage players for next year, reflecting an improving backdrop of care utilization that further fuels optimism in the industry.
- Analyst Rating Upgrade: Following Bank of America's upgrade of UnitedHealth from Neutral to Buy, the stock rose about 5% on Thursday, with analyst Kevin Fischbeck projecting a broader managed care rally if utilization trends continue to improve.
- Attractive Valuations: Despite the positive outlook, UnitedHealth's EV/EBITDA valuation is roughly in line with its five-year average, while CVS Health shows only a ~7% premium, suggesting that the sector still has room for further upside given the favorable setup.
See More
Analysts Upgrade Nvidia and Microsoft on AI Leadership and Margin Resilience
- Nvidia Upgrade: Analyst Ritabrata Das upgraded Nvidia from Hold to Buy, citing its significant benefits from AI infrastructure development, particularly the Blackwell architecture and the high switching costs associated with the CUDA ecosystem, which provide a strong competitive moat.
- Microsoft Rating Reversal: Kevin George upgraded Microsoft from Sell to Buy, noting that AI-driven product launches and improved margin dynamics are offsetting the pressures from high capital expenditures, with net margins continuing to rise despite increased spending.
- UnitedHealth Downgrade: Envision Research downgraded UnitedHealth from Buy to Hold, warning that recent profit margins may be unsustainable due to looming regulatory risks and political pressures in the Medicare Advantage sector, highlighting the volatility in investor sentiment.
- Lululemon Downgrade: Analyst Gary Alexander downgraded Lululemon to Neutral following weak Q1 results and a cut to full-year guidance, expressing concerns over slowing comparable sales and competitive pressures, suggesting that the stock is unlikely to see an upward re-rating in the near term.
See More
Lowe's, Medtronic, and UnitedHealth Raise Dividends
- Lowe's Dividend Increase: Lowe's announced a 4% increase in its quarterly dividend to $1.25 per share, and despite a 14% decline in stock price this year, its 2.4% yield remains significantly above the S&P 500's 1% average.
- Medtronic's Revenue Growth: Medtronic reported an 8.4% annual revenue growth for fiscal 2026, reaching $36.4 billion, and raised its dividend to $0.72, marking the 49th consecutive year of increases, underscoring its appeal as a quality dividend stock.
- UnitedHealth's Dividend Boost: UnitedHealth increased its quarterly dividend by 5% to $2.32 per share, with a 60% rise over the past five years, averaging a compounded annual growth rate of about 10%, providing investors with a hedge against inflation.
- Healthcare Sector Outlook: While Medtronic and UnitedHealth's stock prices have fallen by 15% and risen by 20% respectively this year, their forward P/E ratios of 12 and 21 indicate strong appeal for dividend investors, particularly in the medical devices and health insurance sectors.
See More
Three High-Yield Stocks Increase Dividends
- Lowe's Dividend Increase: Lowe's announced a 4% increase in its quarterly dividend to $1.25 per share, yielding 2.4%, which is significantly higher than the S&P 500's 1%, despite a 14% drop in stock price this year; this move underscores the company's long-standing commitment to dividend payments, as home repairs remain essential for homeowners in the long run.
- Medtronic Annual Performance: Medtronic reported a record revenue of $36.4 billion for fiscal 2026, an 8.4% increase year-over-year, and raised its dividend to $0.72 per share, marking the 49th consecutive year of increases; while the increment is modest, its 3.5% yield continues to attract investors, reflecting its solid position in the medical device sector.
- UnitedHealth Dividend Boost: UnitedHealth increased its quarterly dividend by 5% to $2.32 per share, with a remarkable 60% rise over the past five years, averaging a 10% compound annual growth rate, which not only offsets inflation but also boosts investor confidence in its future performance, as the stock has risen 20% this year while remaining reasonably priced.
- Market Outlook Analysis: All three companies demonstrate strong performance in their respective sectors, and despite market fluctuations, Lowe's and Medtronic's low P/E ratios of 16 and 12 make them attractive options for investors, while UnitedHealth's improved control over medical expenses provides confidence for future growth.
See More
Surge in Options Trading for Healthcare Stocks
- Healthcare Stocks Surge: On Thursday, healthcare stocks outperformed as the broader market rose, with insurers Humana and Centene hitting new highs and UnitedHealth Group nearing its one-year peak, indicating a strong recovery in the sector and increased investor confidence.
- Active Options Trading: The State Street Health Care Select Sector SPDR ETF (XLV) saw 5,300 call options traded on Thursday, significantly outpacing just over 1,000 puts, reflecting bullish sentiment and expectations for future growth in the healthcare industry.
- Eli Lilly Leads Gains: Eli Lilly's stock rose over 4% towards all-time highs, with call options outnumbering puts more than two-to-one, showcasing strong demand for its weight loss drugs and confidence in future profitability.
- Comparative Financial Sector Performance: In contrast to the robust performance of healthcare stocks, options trading in the financial sector appeared muted, with nearly 380,000 options traded in the State Street Financial Select Sector ETF (XLF), indicating a more cautious market outlook for financials.
See More
